{
  "id": "cluster_2_doc4",
  "content": "Medical Digest article 11/20/2023: Hemisphere Oncology expands CAR-T access following successful appeals process. Highlights case where genetic testing documentation (CD19+/CD22+) enabled coverage for PA-4892-LK despite initial denial. 87 similar cases pending nationwide. New provider network requirements being rolled out regionally starting Q1 2024.",
  "metadata": {
    "format": "news_article"
  }
}